About

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Medical Information aims to empower the healthcare community to make informed decisions about our medicines, enabling better outcomes for patients.

Address

C / Quintanavides, 15
28050 Madrid
Spain

Contact details

Medical Information phone number
+39-900 -150 160

Medical Information website
https://www.globalbmsmedinfo.com/ES/sp/CountryPage

Medical Information email
informacion.medica@bms.com

Adverse events and product complaints

Adverse event phone number
+39-900 -150 160

Adverse event email
informacion.medica@bms.com

Company website
https://www.bms.com/es

BMS products

Medicinal products marked withare subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

ABRAXANE®
(nab-paclitaxel)

AZACTAM®
(aztreonam)

BARACLUDE®
(entecavir)

ELIQUIS® (Co-Promoted Pfizer)
(apixaban)

EMPLICITI®
(elotuzumab)

EVOTAZ®
(atazanavir sulfate, cobicistat)

HYDREA®
(hydroxyurea)

IMNOVID®
(pomalidomide)

NIFLACTOL®
(niflumic acid)

NULOJIX®
(belatacept)

OPDIVO® + YERVOY® Regimen
(nivolumab, ipilimumab)

OPDIVO®
(nivolumab)

ORENCIA®
(abatacept)

REVLIMID®
(lenalidomide)

REYATAZ®
(atazanavir sulfate)

SPRYCEL®
(dasatinib)

SUSTIVA®
(efavirenz)

TRIGON®
(triamcinolone acetonide)

VIDAZA®
(azacitidine)

YERVOY®
(ipilimumab)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Last updated: 01/03/2022